You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API docetaxel anhydrous


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing docetaxel anhydrous

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Hospira Inc DOCETAXEL docetaxel anhydrous 0409-0201 ALCOHOL
Hospira Inc DOCETAXEL docetaxel anhydrous 0409-0201 CITRIC ACID MONOHYDRATE
Hospira Inc DOCETAXEL docetaxel anhydrous 0409-0201 POLYETHYLENE GLYCOL 300
Hospira Inc DOCETAXEL docetaxel anhydrous 0409-0201 POLYSORBATE 80
Hospira Inc DOCETAXEL docetaxel anhydrous 0409-2026 ALCOHOL
Hospira Inc DOCETAXEL docetaxel anhydrous 0409-2026 CITRIC ACID MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing docetaxel anhydrous

Company Ingredient NDC Excipient
Sagent Pharmaceuticals docetaxel anhydrous 25021-245 ALCOHOL
Sagent Pharmaceuticals docetaxel anhydrous 25021-245 ANHYDROUS CITRIC ACID
Sagent Pharmaceuticals docetaxel anhydrous 25021-245 POLYSORBATE 80
Sagent Pharmaceuticals docetaxel anhydrous 25021-254 ALCOHOL
Sagent Pharmaceuticals docetaxel anhydrous 25021-254 ANHYDROUS CITRIC ACID
Sagent Pharmaceuticals docetaxel anhydrous 25021-254 POLYETHYLENE GLYCOL 300
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for docetaxel anhydrous

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CITRIC ACID MONOHYDRATE

docetaxel anhydrous drug variants not containing CITRIC ACID MONOHYDRATE

Company Ingredient NDC
Sagent Pharmaceuticals docetaxel anhydrous 25021-245
Sagent Pharmaceuticals docetaxel anhydrous 25021-254
Ingenus Pharmaceuticals LLC docetaxel anhydrous 50742-428
Mylan Institutional LLC docetaxel anhydrous 67457-531
Mylan Institutional LLC docetaxel anhydrous 67457-532
Meitheal Pharmaceuticals Inc docetaxel anhydrous 71288-143
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYSORBATE 80

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group